Search - tctmd.com

Displaying 401 - 420 of 875

Sort: Relevancy | Date

Presentation TCT 2020

TCT 336: Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation: A Patient-Level, Multi-Center Analysis

Presenter: Benjamin Hibbert

October 14, 2020

Presentation TCT 2020

TCT 092: Initial Single Center Experience With Transfemoral Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Regurgitation

Presenter: Shawn Gogia

October 14, 2020

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Shelley Wood

September 29, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

Presentation TCT 2019

COAPT: Cost-Effectiveness Analysis From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Presenter: Suzanne Baron

September 29, 2019

Presentation TCT 2019

TRILUMINATE Trial: 6-Month Outcomes of Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation

Presenter: Georg Nickenig

September 28, 2019

Presentation TCT 2019

TRUE Registry: A New Prognostic Risk Score for Risk Stratification of Patients With Severe Tricuspid Regurgitation

Presenter: Alexander Lauten

September 28, 2019

Presentation TCT 2019

Mitral Regurgitation as a Target for Heart Failure, and the Relevance of Proportionate vs. Disproportionate MR

Presenter: Susan Joseph

September 28, 2019

Presentation TCT 2019

State-of-the-Art Medical Therapy for Treatment of Tricuspid Regurgitation and Its Effect on Prognosis

Presenter: Linda Gillam

September 28, 2019

Presentation TCT 2019

Case Resolution: How We Treated Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Presenter: Howard Herrmann

September 28, 2019

Presentation TCT 2019

Case Introduction: Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Presenter: Howard Herrmann

September 28, 2019

Presentation TCT 2019

Combined Low-Flow, Low-Gradient Aortic Stenosis and Functional Mitral Regurgitation: A Diagnostic Challenge

Presenter: Rebecca Hahn

September 28, 2019

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

Presentation TCT 2019

Trial Design for Tricuspid Devices: Perspectives From the FDA

Presenter: Jaime Raben

September 28, 2019

Presentation TCT 2019

Emerging Catheter-Based Therapies: Thinking Outside the Box

Presenter: Francesco Maisano

September 28, 2019

Presentation TCT 2019

Step-by-Step Tricuspid Clipping: Echo and Intervention Working Together

Presenter: Richard Bae

September 28, 2019

Presentation TCT 2019

Transcatheter TR Therapies: Lessons Learned From the International TriValve Registry

Presenter: Maurizio Taramasso, MD

September 28, 2019

Presentation TCT 2019

Building a Tricuspid Valve Program: Early Lessons, Challenges, and Opportunities

Presenter: Charles Davidson

September 28, 2019

Presentation TCT 2019

COAPT: 3-Year Outcomes From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Presenter: Michael Mack

September 28, 2019

Presentation TCT 2019

Redefining Patient Selection and Therapeutic Approach for Tricuspid Valve Interventions

Presenter: Azeem Latib

September 28, 2019

Advertisement

TCT 336: Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation: A Patient-Level, Multi-Center Analysis

TCT 092: Initial Single Center Experience With Transfemoral Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Regurgitation

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

COAPT: Cost-Effectiveness Analysis From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

TRILUMINATE Trial: 6-Month Outcomes of Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation

TRUE Registry: A New Prognostic Risk Score for Risk Stratification of Patients With Severe Tricuspid Regurgitation

Mitral Regurgitation as a Target for Heart Failure, and the Relevance of Proportionate vs. Disproportionate MR

State-of-the-Art Medical Therapy for Treatment of Tricuspid Regurgitation and Its Effect on Prognosis

Case Resolution: How We Treated Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Case Introduction: Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Combined Low-Flow, Low-Gradient Aortic Stenosis and Functional Mitral Regurgitation: A Diagnostic Challenge

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Trial Design for Tricuspid Devices: Perspectives From the FDA

Emerging Catheter-Based Therapies: Thinking Outside the Box

Step-by-Step Tricuspid Clipping: Echo and Intervention Working Together

Transcatheter TR Therapies: Lessons Learned From the International TriValve Registry

Building a Tricuspid Valve Program: Early Lessons, Challenges, and Opportunities

COAPT: 3-Year Outcomes From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Redefining Patient Selection and Therapeutic Approach for Tricuspid Valve Interventions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content